Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Rapid Free Communications


Serum Levels of the Soluble Receptor for Advanced Glycation End Products are Reduced in Children with Hashimoto's Thyroiditis
aPediatric Unit, Department of Human Pathology in Adulthood and Childhood, University of Messina, Messina, Italy; bEndocrinology Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy; cDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy
Analysis of Chosen Polymorphisms rs7138803 A/G - FAIM2, rs7093069 C/T - IL-2RA, rs5742909 C/T - CTLA-4 in Pathogenesis of Hashimoto's Thyroiditis in Children
aDepartment of Paediatrics, Endocrinology, Diabetology with Cardiology Division Medical University of Białystok, Białystok, Poland; bSoftware Department, Faculty of Computer Science, Białystok University of Technology, Białystok, Poland; cDepartment of Endocrinology and Diabetes with Internal Medicine, Medical University in Białystok, Białystok, Poland; dDivision of Cardiology, Internal Affairs and Administration Ministry Hospital in Białystok, Białystok, Poland; eDepartment of Human Pathology of Adulthood abd Childhood, University of Messina, Messina, Italy
Incidence and Treatment Outcome of Childhood Thyrotoxicosis
aDepartment of Pediatrics, Örebro University, Örebro, Sweden; bFaculty of Medicine and Health, University Health Care Research Center, Örebro University, Örebro, Sweden
Evidence for a Founder Effect in Multiple Endocrine Neoplasia 2
aDepartment of Molecular Genetics, Function and Therapy, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; bDivision of Pediatric Endocrinology, Paedi Center for Specialized Pediatrics, Nicosia, Cyprus; cSt George’s, University of London Medical School at the University of Nicosia, Nicosia, Cyprus; dNuclear Medicine Department, Bank of Cyprus Oncology Center, Nicosia, Cyprus; eMolecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; fDepartment of Clinical Genetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; gDasoupolis Endocrinology Center, Andrea Dimitriou Street Dasoupolis, Nicosia, Cyprus; hDepartment of Cardiovascular Genetics and the Laboratory of Forensic Genetics, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus; iDivision of Pediatric Endocrinology, Makarios III Hospital, Nicosia, Cyprus; jCyprus School of Molecular Medicine, Nicosia, Cyprus; kDepartment of Clinical Genetics, Makarios III Hospital, Nicosia, Cyprus
DUOX2 Deficiency in Quebec: From Life-Threatening Compressive Goiter in Infancy to Lifelong Euthyroidism
aUniversity of Montreal, Montreal, Canada; bUniversité Laval, Québec City, Canada; cUniversité Libre de Bruxelles, Brussels, Belgium; dUniversity of Basel, Basel, Switzerland